- Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembolica RegistryPublication without faculty affiliation
- Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis2018 | First Faculty of Medicine
- Dulaglutide and Cardiovascular and Heart Failure Outcomes in Patients With and Without Heart Failure: A Post-hoc Analysis from the REWIND Randomized Trial2022 | Publication without faculty affiliation
- Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome2020 | Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. PM1116197Publication without faculty affiliation
- Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure2021 | Faculty of Medicine in Pilsen
- CT or Invasive Coronary Angiography in Stable Chest Pain2022 | Second Faculty of Medicine
- Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes2019 | Publication without faculty affiliation
- Canagliflozin2023 | First Faculty of Medicine
- Is There Really an Association of High Circulating Adiponectin Concentration and Mortality or Morbidity Risk in Stable Coronary Artery Disease?2020 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- The power and wisdom of prevention. Cardiovascular risk, new challenge, and approach to PLWH2022 | Third Faculty of Medicine, First Faculty of Medicine
- Clinial aspects of ASA resistance2017 | First Faculty of Medicine
- OCT guidance during stent implantation in primary PCI: A randomized multicenter study with nine months of optical coherence tomography follow-up2018 | Faculty of Medicine in Hradec Králové
- Benefits and risks of clopidogrel use in patients with coronary artery disease: Evidence from randomized studies and registries2008 | Central Library of Charles University, Third Faculty of Medicine
- "Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: An intravascular ultrasound study"2006 | Publication without faculty affiliation
- Randomized Comparison of Endothelial Progenitor Cells Capture Stent Versus Cobalt-Chromium Stent for Treatment of ST-Elevation Myocardial Infarction. Six-Month Clinical, Angiographic, and IVUS Follow-Up2010 | Central Library of Charles University, Third Faculty of Medicine
- Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)2010 | Second Faculty of Medicine
- Role of sitagliptin in the treatment of type 2 diabetes based on the results of the TECOS study2016 | Second Faculty of Medicine
- Cardiovascular safety of testosterone replacement therapy2023 | Third Faculty of Medicine
- Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial2017 | Second Faculty of Medicine
- In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events2020 | Publication without faculty affiliation
- Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial2022 | Publication without faculty affiliation
- Randomized comparison of 9-month stent strut coverage of biolimus and everolimus drug-eluting stents assessed by optical coherence tomography in patients with ST-segment elevation myocardial infarction. Long-term (5-years) clinical follow-up (ROBUST trial)2023 | Publication without faculty affiliation
- Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention2012 | Faculty of Medicine in Pilsen
- Prognostic Value of MicroRNAs in Patients after Myocardial Infarction: A Substudy of PRAGUE-182019 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants2021 | Publication without faculty affiliation
- Polypill Strategy in Secondary Cardiovascular Prevention2022 | First Faculty of Medicine
- Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention2018 | Third Faculty of Medicine
- The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus2021 | Publication without faculty affiliation
- Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study2019 | Third Faculty of Medicine